Tablet Coatings Market - Emerging Trends to Bring Major Revolution in Global Healthcare Industry

Market Size Estimation:

This study's market size estimations and forecasts are the result of combining a top-down (evaluation of utilization/adoption/penetration trends by polymer type, functionality, type, end user, and region) and bottom-up (segmental analysis of important segments) methodology.

Projected Surge in Revenue Generation:

With a compound annual growth rate (CAGR) of 5.6%, the tablet coatings market is expected to reach a valuation of USD 969 million by 2025 from its estimated USD 739 million in 2020.

Major Growth Boosting Factors:

The pharmaceutical industry's growth and the rise in R&D in this area are the main factors driving this market's expansion. The market is expanding thanks to the burgeoning nutraceutical business, the fast expanding biopharmaceuticals sector, the growing generics market, and the increased use of orphan medications. Furthermore, there are a lot of prospects for market expansion due to the pharmaceutical industry's growing emphasis on emerging markets and the growing outsourcing of operations to these nations. The growing emphasis on technology developments in specialized markets also presents large growth prospects for companies involved in this industry.

However, throughout the projected period, the market's expansion is anticipated to be constrained by the tightening regulations pertaining to the licensing of pharmaceuticals and excipients, as well as the high cost of the microencapsulation process.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150774403

Data Triangulation:

The entire tablet coatings market was split into a number of categories and subsegments when the market size was determined. In order to finalize the market engineering process and obtain precise statistics for every segment and subsegment, data triangulation and market breakdown techniques were utilized, if appropriate.

End Users:

The pharmaceutical industry end-user segment is expected to account for the largest share of the tablet coatings market

The tablet coatings market, by end-user, is segmented into pharmaceutical and nutraceutical industry. The pharmaceutical industry segment accounted for the largest market share in 2019. The demand for tablet coatings in the pharmaceutical industry is largely driven by the increasing number of drugs launched as tablet formulations and growing prevalence of diseases for which tablet-based formulations form the primary treatment. The rising demand for innovative drug delivery formulations is also supporting the growth of the tablet coatings market for the pharmaceutical industry.

Geographical Growth Dynamics:

Asia Pacific is expected to account for the highest CAGR for players operating in the tablet coatings market

The Asia Pacific tablet coatings market is expected to grow at the highest CAGR from 2020 to 2025. Increase in outsourcing of drug manufacturing to specialized contract manufacturing organizations (CMOs), rising number of companies setting up manufacturing units in these countries, favorable government regulations, low labor and manufacturing costs, and the large base for the generation of generics & biologics are factors expected to drive the growth of the market during the forecast period.

Global Key Players:

The prominent players in this market are Colorcon Inc. (US), Sensient Technologies Corporation (US), BASF SE (Germany), Evonik Industries AG (Germany), Ashland Global Holdings Inc. (US), DuPont De Numeours Inc. (US), Kerry Group plc (Ireland), Roquette Freres (France), Eastman Chemical Company (US), Air Liquide S.A. (France), and Merck KGaA (Germany).

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=150774403

Tablet Coatings Market - Emerging Trends to Feed the Global Growth

 COVID-19 Impact on Global Tablet Coatings Market

COVID-19 has given momentum to the pharmaceutical and nutraceutical market. Currently, there is a high demand for pharmaceutical products to treat COVID-19. This is expected to boost the demand for products such as tablet coating excipients. The clinical trial pipeline for COVID-19 includes a list of 155 molecules in various stages of development. As the maximum number of molecules are repurposed drugs that are already approved for other infections and inflammatory diseases, higher stages of development (namely phase 2 trials) hold the largest share of the drug development pipeline.

Moreover, compassionate use allows for the use of an unlicensed drug (licenses can take years or decades) when no other options are available for treating high-risk patients. On April 6, 2020, RedHill Biopharma announced that it had received authorization from the Italian National Institute for Infectious Diseases and the Central Italian Ethics Committee (EC) for an expanded access program (EAP), allowing the immediate and compassionate use of its investigational drug, opaganib (Yeliva), in Italy for patients with confirmed COVID-19 infections with life-threatening clinical manifestations. Considering such developments, it is expected that the production and use of unlicensed drugs are expected to increase in the coming years. This in turn is expected to drive the demand for tablet coatings.

Major Growth Driver: Rising adoption of orphan drugs

An orphan drug is a pharmaceutical agent developed to treat rarely occurring medical conditions referred to as orphan diseases. Owing to the surge in the number of treatments for rare diseases, the pharmaceutical industry is expected to witness a rising demand for pharmaceutical ingredients, including APIs and excipients. According to the US NIH, there are as many as 7,000 conditions classified as rare by US standards (affecting less than 200,000 Americans). Since the introduction of the Orphan Drug Act, only about 600 drugs have been approved, leaving most rare diseases without any licensed treatment.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150774403

Opportunity: Growth in the biosimilars market

Biosimilars are cost-effective because they are not required to comply with the stringent requirements imposed by regulatory authorities, as they are generic versions of patented biologic drugs. Over the last decade, over 200 biologics have been approved by the US FDA. As patents and exclusivity periods for these biologics begin to expire, an opportunity for the development of follow-on biologics or biosimilars by a different sponsor is created.

ccording to the World Preview 2018 report, sales of up to USD 251 billion are at risk between 2018 and 2024, which points towards the fact that the pharmaceutical industry has just entered a second patent cliff era where top biologic blockbusters will be challenged by biosimilars. The expiration of patents and other intellectual property rights for originator biologicals is expected to open up opportunities for biosimilars to enter the market. Biologics are expected to contribute to around half of the revenue generated by the top 100 pharmaceutical products.

Challenge: Changing trade policies between countries

With the current changes in government policies all over the world, upcoming trade policies could prove to be a challenge for the pharmaceutical industry, and in turn, the excipients industry. Trade between the developing countries who are considered to be pharmerging countries such as China, India, and Brazil and developed countries like the US and European countries, who are top markets in the industry, could be severely affected. BREXIT is another pressing issue in this market. Although the effects of BREXIT on the pharmaceutical industry are still unclear, companies like Novartis, Astra Zeneca, and Roche have already shifted manufacturing sites in order to reduce any further risks.

Recent Developments:

# In 2020, Colorcon launched the Acryl-EZE II film coating line which extends the pH range covered by its enteric coatings.
# In 2020, Evonik launched the EUDRATEC Fasteric releases, an advanced oral drug delivery technology that provides enteric protection followed by rapid, homogeneous release for effective targeting of the upper small intestine.
# In 2019, Ashland announced the launch of Aquarius Nutra TF, which provides titanium oxide-based coating to tablets in the European market.
# In 2019, Kerry Group opened its new USD 22 million (EUR 20 million) state-of-the-art facility in Bangalore, India to serve the Taste & Nutrition business division’s global and regional customers in the South West Asia region.
# In 2017, BASF Group opened the Innovation Campus Asia Pacific in India, marking the largest R&D investment in South Asia. The company invested USD 61.6 million (EUR 50 million) in this center to increase its global and regional research activities.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=150774403

The pharmaceutical industry end-user segment is expected to account for the largest share of the tablet coatings market

The tablet coatings market, by end-user, is segmented into pharmaceutical and nutraceutical industry. The pharmaceutical industry segment accounted for the largest market share in 2019. The demand for tablet coatings in the pharmaceutical industry is largely driven by the increasing number of drugs launched as tablet formulations and growing prevalence of diseases for which tablet-based formulations form the primary treatment. The rising demand for innovative drug delivery formulations is also supporting the growth of the tablet coatings market for the pharmaceutical industry.

Asia Pacific is expected to account for the highest CAGR for players operating in the tablet coatings market

The Asia Pacific tablet coatings market is expected to grow at the highest CAGR from 2020 to 2025. Increase in outsourcing of drug manufacturing to specialized contract manufacturing organizations (CMOs), rising number of companies setting up manufacturing units in these countries, favorable government regulations, low labor and manufacturing costs, and the large base for the generation of generics & biologics are factors expected to drive the growth of the market during the forecast period.

Tablet Coatings Market worth $969 million by 2025 - Exclusive Report by MarketsandMarkets™

 The Tablet Coatings Market is projected to reach USD 969 million by 2025 from USD 739 million in 2020, at a CAGR of 5.6% during the forecast period, according to a new report by MarketsandMarkets™. Growth in this market is majorly driven by the growing pharmaceutical industry coupled with the increasing R&D activities taking place in this field. Also, the growing generics market, rapidly growing biopharmaceuticals sector, growing nutraceutical industry, and the rising adoption of orphan drugs are supporting the growth of the market.

Additionally, the shifting focus of pharmaceutical manufacturing to emerging markets along with the increasing outsourcing of operations to these countries and the growing biologics and biosimilars industry present significant opportunities for market growth. The rising focus on sports nutrition and the technological advancements taking place in niche market areas also offers significant growth opportunities for players operating in this space.

Browse in-depth TOC on "Tablet Coatings Market”
141 – Tables
55 – Figures
243 – Pages

On the other hand, the increasing regulatory stringency regarding the approval of drugs and excipients along with the cost and time-intensive drug development process; the high cost associated with the microencapsulation process and the unfavorable drug price control policies are expected to restrain the growth of this market during the forecast period. Additionally, increasing safety & quality concerns, increasing penetration of counterfeit drugs, changing trade policies among countries and alcohol dose-dumping of sustained-release dosages pose significant challenges to the growth of this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150774403

The cellulose polymers segment is expected to grow at the highest CAGR during the forecast period

Based on the polymers used for manufacture of tablet coatings, the cellulosic polymers segment accounted for the largest share of the global tablet coatings market in 2019. The large share of this segment can be attributed to the high adoption of these polymers owing to the ability to form coatings generally having acceptable properties such as good film strength, aqueous solubility, and compressibility, less sensitivity to wet granulation, flowability, and better tableting at a low price. Factors such as the the global regulatory acceptance and ready availability from a number of vendors are also the adoption of these polymers for coating applications.

The non-functional non-modifying coatings segment is expected to account for the largest share of the tablet coatings market

Based on functionality, the non-functional non-modifying coatings segment commanded the largest share in 2019. The large share of this segment can be attributed to high use of these coatings for the manufacture of immediate-release dosage forms. Also, these coats offer the advantages of protection against light and moisture, easy identification, improved swallowability, taste masking, mechanical strength, and improved safety and ease of handling. This is further supporting their adoption in the manufacture of oral solid dosages. Furthermore, the growing demand for innovative drug delivery formulations and increasing focus on nutraceuticals and dietary supplements using immediate-release coatings will continue to drive market growth.

The film-coated tablets segment is expected to grow at the highest rate during the forecast period

The tablet coatings market is segmented into film-coated, sugar-coated, gelatin-coated, enteric-coated tablets and other tablet coatings based on type. In 2019, the film-coated segment dominated the tablet coatings market, by type, and is also expected to grow at the highest CAGR during the forecast period. The demand for film-coated tablets is high in the pharmaceutical industry due to the benefits of shorter processing times, fairly thin coats obtained as compared to other coating type, high resistance to mechanical influences, and addition of functional properties to the tablets. These coatings also minimize the risk of medication errors leveraging pigments/ colors for identification and also improves patient compliance through aesthetic appeal which further support market growth.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=150774403

The pharmaceutical industry end-user segment is expected to account for the largest share of the tablet coatings market

The tablet coatings market, by end-user, is segmented into pharmaceutical and nutraceutical industry. The pharmaceutical industry segment accounted for the largest market share in 2019. The demand for tablet coatings in the pharmaceutical industry is largely driven by the increasing number of drugs launched as tablet formulations and growing prevalence of diseases for which tablet-based formulations form the primary treatment. The rising demand for innovative drug delivery formulations is also supporting the growth of the tablet coatings market for the pharmaceutical industry.

Asia Pacific is expected to account for the highest CAGR for players operating in the tablet coatings market

The Asia Pacific tablet coatings market is expected to grow at the highest CAGR from 2020 to 2025. Increase in outsourcing of drug manufacturing to specialized contract manufacturing organizations (CMOs), rising number of companies setting up manufacturing units in these countries, favorable government regulations, low labor and manufacturing costs, and the large base for the generation of generics & biologics are factors expected to drive the growth of the market during the forecast period.

The prominent players in this market are Colorcon Inc. (US), Sensient Technologies Corporation (US), BASF SE (Germany), Evonik Industries AG (Germany), Ashland Global Holdings Inc. (US), DuPont De Numeours Inc. (US), Kerry Group plc (Ireland), Roquette Freres (France), Eastman Chemical Company (US), Air Liquide S.A. (France), and Merck KGaA (Germany).

Browse Adjacent Market: Pharmaceuticals Market Research Reports & Consulting

Related Reports:

Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) - Global Forecast to 2027
https://www.marketsandmarkets.com/Market-Reports/pharma-excipients-market-956.html

Tablet Coatings Market - Major Revenue Growth is Expected in the Near Future

 Major Growth Influencing Factors:

Growth in this market is majorly driven by the growing pharmaceutical industry coupled with the increasing R&D activities taking place in this field. The growing generics market, rapidly growing biopharmaceuticals sector, growing nutraceutical industry, and the rising adoption of orphan drugs are supporting the growth of the market. Moreover, the shifting focus of pharmaceutical manufacturing to emerging markets along with the increasing outsourcing of operations to these countries present significant opportunities for market growth.

Additionally, the rising focus on technological advancements in niche market areas also offers significant growth opportunities for players operating in this space. However, the increasing regulatory stringency regarding the approval of drugs and excipients, the high cost associated with the microencapsulation process are expected to restrain the growth of this market during the forecast period.

Expected Revenue Gains:

The tablet coatings market is projected to reach USD 969 million by 2025 from USD 739 million in 2020, at a CAGR of 5.6% during the forecast period.

Market Size Estimation:

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by polymer type, functionality, type, end user, and region).

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150774403

Data Triangulation:

After arriving at the market size, the total tablet coatings market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.

COVID-19 Impact on Global Tablet Coatings Market:

COVID-19 has given momentum to the pharmaceutical and nutraceutical market. Currently, there is a high demand for pharmaceutical products to treat COVID-19. This is expected to boost the demand for products such as tablet coating excipients. The clinical trial pipeline for COVID-19 includes a list of 155 molecules in various stages of development. As the maximum number of molecules are repurposed drugs that are already approved for other infections and inflammatory diseases, higher stages of development (namely phase 2 trials) hold the largest share of the drug development pipeline. Moreover, compassionate use allows for the use of an unlicensed drug (licenses can take years or decades) when no other options are available for treating high-risk patients.

On April 6, 2020, RedHill Biopharma announced that it had received authorization from the Italian National Institute for Infectious Diseases and the Central Italian Ethics Committee (EC) for an expanded access program (EAP), allowing the immediate and compassionate use of its investigational drug, opaganib (Yeliva), in Italy for patients with confirmed COVID-19 infections with life-threatening clinical manifestations. Considering such developments, it is expected that the production and use of unlicensed drugs are expected to increase in the coming years. This in turn is expected to drive the demand for tablet coatings.

The pharmaceutical industry end-user segment is expected to account for the largest share of the tablet coatings market

The tablet coatings market, by end-user, is segmented into pharmaceutical and nutraceutical industry. The pharmaceutical industry segment accounted for the largest market share in 2019. The demand for tablet coatings in the pharmaceutical industry is largely driven by the growing prevalence of diseases for which tablet-based formulations form the primary treatment. The rising demand for innovative drug delivery formulations is also supporting the growth of the tablet coatings market for the pharmaceutical industry.

Europe is expected to account for the largest share of the tablet coatings market in 2019

In 2019, Europe accounted for the largest share of the tablet coatings market, followed by North America, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of this market segment can be characterized by the presence of a number of pharmaceutical giants with large production capacities leading to a high consumption of excipients. The growing emphasis on superior pharmaceutical products, generics, and biosimilars has also led to the increase in the demand for novel excipients, which, in turn, is expected to drive the market growth in this region in the coming years.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=150774403

Key Market Players:

The prominent players in this market are Colorcon Inc. (US), Sensient Technologies Corporation (US), BASF SE (Germany), Evonik Industries AG (Germany), Ashland Global Holdings Inc. (US), DuPont De Numeours Inc. (US), Kerry Group plc (Ireland), Roquette Freres (France), Eastman Chemical Company (US), Air Liquide S.A. (France), and Merck KGaA (Germany).

Recent Developments:

# In 2020, Colorcon launched the Acryl-EZE II film coating line which extends the pH range covered by its enteric coatings.

# In 2020, Evonik launched the EUDRATEC Fasteric releases, an advanced oral drug delivery technology that provides enteric protection followed by rapid, homogeneous release for effective targeting of the upper small intestine.

# In 2019, Ashland announced the launch of Aquarius Nutra TF, which provides titanium oxide-based coating to tablets in the European market.

# In 2019, Kerry Group opened its new USD 22 million (EUR 20 million) state-of-the-art facility in Bangalore, India to serve the Taste & Nutrition business division’s global and regional customers in the South West Asia region.

# In 2017, BASF Group opened the Innovation Campus Asia Pacific in India, marking the largest R&D investment in South Asia. The company invested USD 61.6 million (EUR 50 million) in this center to increase its global and regional research activities.

Find Out Detailed Information@
https://www.marketsandmarkets.com/Market-Reports/tablet-coatings-market-150774403.html

Major Technological Innovations are Expected in the Global Tablet Coatings Market

 Research Methodologies Followed:

Primary Research:

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the tablet coatings market.

The primary sources from the demand side include industry experts such as experts from drugs manufacturing companies, nutraceutical companies, and contract manufacturing organizations.

Secondary Research:

This research study involved the use of comprehensive secondary sources; directories and databases such as D&B, Bloomberg Business, and Factiva; and white papers, annual reports, and company house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global tablet coatings market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, technology perspectives, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150774403

Projected Revenue Surge:

The tablet coatings market is projected to reach USD 969 million by 2025 from USD 739 million in 2020, at a CAGR of 5.6% during the forecast period.

Market Size Estimation:

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by polymer type, functionality, type, end user, and region).

Data Triangulation:

After arriving at the market size, the total tablet coatings market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.

Global Industry Growth Influencing Factors:

Growth in this market is majorly driven by the growing pharmaceutical industry coupled with the increasing R&D activities taking place in this field. Also, the growing generics market, rapidly growing biopharmaceuticals sector, growing nutraceutical industry, and the rising adoption of orphan drugs are supporting the growth of the market.

Additionally, the shifting focus of pharmaceutical manufacturing to emerging markets along with the increasing outsourcing of operations to these countries and the growing biologics and biosimilars industry present significant opportunities for market growth. The rising focus on sports nutrition and the technological advancements taking place in niche market areas also offers significant growth opportunities for players operating in this space.

On the other hand, the increasing regulatory stringency regarding the approval of drugs and excipients along with the cost and time-intensive drug development process; the high cost associated with the microencapsulation process and the unfavorable drug price control policies are expected to restrain the growth of this market during the forecast period.

Additionally, increasing safety & quality concerns, increasing penetration of counterfeit drugs, changing trade policies among countries and alcohol dose-dumping of sustained-release dosages pose significant challenges to the growth of this market.

End Users:

The pharmaceutical industry end-user segment is expected to account for the largest share of the tablet coatings market

The tablet coatings market, by end-user, is segmented into pharmaceutical and nutraceutical industry. The pharmaceutical industry segment accounted for the largest market share in 2019. The demand for tablet coatings in the pharmaceutical industry is largely driven by the increasing number of drugs launched as tablet formulations and growing prevalence of diseases for which tablet-based formulations form the primary treatment. The rising demand for innovative drug delivery formulations is also supporting the growth of the tablet coatings market for the pharmaceutical industry.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=150774403

Geographical Growth Scenario:

Asia Pacific is expected to account for the highest CAGR for players operating in the tablet coatings market

The Asia Pacific tablet coatings market is expected to grow at the highest CAGR from 2020 to 2025. Increase in outsourcing of drug manufacturing to specialized contract manufacturing organizations (CMOs), rising number of companies setting up manufacturing units in these countries, favorable government regulations, low labor and manufacturing costs, and the large base for the generation of generics & biologics are factors expected to drive the growth of the market during the forecast period.

Colorcon Inc. (US), Sensient Technologies Corporation (US), BASF SE (Germany) are the leading players in the Tablet Coatings Market

The tablet coatings market is projected to reach USD 969 million by 2025 from USD 739 million in 2020, at a CAGR of 5.6% during the forecast period. Growth in this market is majorly driven by the growing pharmaceutical industry coupled with the increasing R&D activities taking place in this field. Also, the growing generics market, rapidly growing biopharmaceuticals sector, growing nutraceutical industry, and the rising adoption of orphan drugs are supporting the growth of the market.

The shifting focus of pharmaceutical manufacturing to emerging markets along with the increasing outsourcing of operations to these countries and the growing biologics and biosimilars industry present significant opportunities for market growth. The rising focus on sports nutrition and the technological advancements taking place in niche market areas also offers significant growth opportunities for players operating in this space. On the other hand, the increasing regulatory stringency regarding the approval of drugs and excipients along with the cost and time-intensive drug development process; the high cost associated with the microencapsulation process and the unfavorable drug price control policies are expected to restrain the growth of this market during the forecast period.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150774403

The global tablet coatings market is consolidated at the top, with a large number of leading market players based in developed countries. The prominent players in this market are Colorcon Inc. (US), Sensient Technologies Corporation (US), BASF SE (Germany), Evonik Industries AG (Germany), Ashland Global Holdings Inc. (US), DuPont De Numeours Inc. (US), Kerry Group plc (Ireland), Roquette Freres (France), Eastman Chemical Company (US), Air Liquide S.A. (France), Merck KGaA (Germany), Corel Pharma Chem (India), Biogrund GmbH (Germany), Ideal Cures Pvt. Ltd. (India), Wincoat Colours & Coatings Pvt. Ltd. (India), Spectrum Chemical Mfg. Corp. (US), Coating Place, Inc. (US), Lubrizol Corporation (US), Aquadry Pharma Pvt. Ltd. (India), and Aries Exim Pvt. Ltd. (India).

However, in the last few years, a number of smaller players have emerged from niche markets and are competing with global players based on price and technological innovation. Due to the intense competition in the market, major market players are increasingly focusing on expanding their geographic presence into high-growth emerging markets and strengthening their competitiveness in the market by acquiring smaller players with desired technological capabilities or geographic presence.

Colorcon held the leading position in the tablet coatings market in 2019. The company a wide range of immediate-release, enteric-release and sustained-release tablet coatings, along with controlled-release excipients. Colorcon is also engaged in offering a wide range of services for pharmaceutical and nutraceutical formulation development. These services range from dissolution design and patient adherence to productivity, stability, and product authentication services.

The company’s Colorcon Academy offers a series of professional programs developed to increase your technical knowledge and regulatory understanding in the areas of film coating, core formulation, excipient selection and controlled release of solid oral dosage forms. The company has a strong geographic presence established through its manufacturing and distribution facilities, across the globe. Furthermore, the company significantly invests in R&D activities to add innovative technologies and products to its portfolio. The company intends to strengthen its presence in the market by delivering superior solutions and choices to customers. The firm strongly believes that investments in R&D offer great potential for short and long-term growth.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=150774403

Sensient Technologies Corporation held the second position in the global market. The company has a diversified product portfolio, which comprises of a wide range of immediate release and modified release tablet coating excipients. Sensient’s leading position in the market is attributed to its research and development activities, strong manufacturing capabilities, and wide distribution footprint across the world, which enables it to serve customers in more than 150 countries.

The company’s growth strategy for the pharmaceutical excipients business mainly concentrates on expanding its product portfolio and meet rising consumer demand. The company incessantly focuses on the development of the specialty chemicals business by investing in new product discovery. In addition to this, the company’s strategic priority is to leverage its position in the market by focusing on product launches through customer-focused innovation, which enables it to target a larger customer base and diversify its revenue streams.

Global Tablet Coatings Market is Expecting Huge Monetary Gains in Near Future

 Major Growth Boosting Factors:

Growth in this market is majorly driven by the growing pharmaceutical industry coupled with the increasing R&D activities taking place in this field. Also, the growing generics market, rapidly growing biopharmaceuticals sector, growing nutraceutical industry, and the rising adoption of orphan drugs are supporting the growth of the market.

Additionally, the shifting focus of pharmaceutical manufacturing to emerging markets along with the increasing outsourcing of operations to these countries and the growing biologics and biosimilars industry present significant opportunities for market growth. The rising focus on sports nutrition and the technological advancements taking place in niche market areas also offers significant growth opportunities for players operating in this space.

Expected Revenue Surge:

The tablet coatings market is projected to reach USD 969 million by 2025 from USD 739 million in 2020, at a CAGR of 5.6% during the forecast period.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150774403

Growth Restraining Factors:

On the other hand, the increasing regulatory stringency regarding the approval of drugs and excipients along with the cost and time-intensive drug development process; the high cost associated with the microencapsulation process and the unfavorable drug price control policies are expected to restrain the growth of this market during the forecast period.

Additionally, increasing safety & quality concerns, increasing penetration of counterfeit drugs, changing trade policies among countries and alcohol dose-dumping of sustained-release dosages pose significant challenges to the growth of this market.

Global Leaders:

The global tablet coatings market is consolidated at the top, with a large number of leading market players based in developed countries.

The prominent players in this market are Colorcon Inc. (US), Sensient Technologies Corporation (US), BASF SE (Germany), Evonik Industries AG (Germany), Ashland Global Holdings Inc. (US), DuPont De Numeours Inc. (US), Kerry Group plc (Ireland), Roquette Freres (France), Eastman Chemical Company (US), Air Liquide S.A. (France), Merck KGaA (Germany), Corel Pharma Chem (India), Biogrund GmbH (Germany), Ideal Cures Pvt. Ltd. (India), Wincoat Colours & Coatings Pvt. Ltd. (India), Spectrum Chemical Mfg. Corp. (US), Coating Place, Inc. (US), Lubrizol Corporation (US), Aquadry Pharma Pvt. Ltd. (India), and Aries Exim Pvt. Ltd. (India).

However, in the last few years, a number of smaller players have emerged from niche markets and are competing with global players based on price and technological innovation. Due to the intense competition in the market, major market players are increasingly focusing on expanding their geographic presence into high-growth emerging markets and strengthening their competitiveness in the market by acquiring smaller players with desired technological capabilities or geographic presence.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=150774403

The pharmaceutical industry end-user segment is expected to account for the largest share of the tablet coatings market

The tablet coatings market, by end-user, is segmented into pharmaceutical and nutraceutical industry. The pharmaceutical industry segment accounted for the largest market share in 2019. The demand for tablet coatings in the pharmaceutical industry is largely driven by the increasing number of drugs launched as tablet formulations and growing prevalence of diseases for which tablet-based formulations form the primary treatment. The rising demand for innovative drug delivery formulations is also supporting the growth of the tablet coatings market for the pharmaceutical industry.

Asia Pacific is expected to account for the highest CAGR for players operating in the tablet coatings market

The Asia Pacific tablet coatings market is expected to grow at the highest CAGR from 2020 to 2025. Increase in outsourcing of drug manufacturing to specialized contract manufacturing organizations (CMOs), rising number of companies setting up manufacturing units in these countries, favorable government regulations, low labor and manufacturing costs, and the large base for the generation of generics & biologics are factors expected to drive the growth of the market during the forecast period.